Risky Medicine: How COI May Affect Clinical Guidelines and Decision Making

This lecture series highlights advocacy and policy experts who provide technical assistance and leadership development for physicians, residents, and medical students interested in conflict-of-interest reform efforts. The lecture was aired live on Wednesday, October 1, 2014.
Slide Presentation – link
Lecture Recording (58:28)
Written Notes (forthcoming)

Risky Medicine:
How COI May Affect Clinical Guidelines and Decision Making 


Featured Speaker:

Lisa Cosgrove, PhD
Professor at the University of Massachusetts, Boston

Professor Cosgrove will discuss her research regarding questions and dilemmas that arise when individuals or professional organizations with financial conflicts of Interest are involved in the development of clinical practice guidelines and diagnostic tools, including revisions included in the DSM V. She will discuss research she has conducted which examines the type and extent of financial association between authors of diagnostic and treatment guidelines and the pharmaceutical industry and suggestions for recognizing such associations, implications and policy recommendations that would help to reduce potential conflicts.

About our speaker:

Lisa Cosgrove is a Professor at the University of Massachusetts, Boston and a Network Lab Fellow at the Edmond J. Safra Center for Ethics, Harvard University. She received her PhD in Clinical Psychology from Duquesne University. She is co-editor of “Bias in Psychiatric Diagnosis and a contributing editor to Psychiatric Ethics and the Rights of Persons with Mental Disabilities in Institutions and the Community.” She has published over 40 peer-reviewed journal articles and book chapters, and her research on conflict of interest has been cited and discussed in major media outlets. Recent publications include “Antidepressants and breast and ovarian cancer risk: A systematic review of the epidemiological and pre-clinical literature and researchers’ financial associations with industry” (with co-authors Ling, Creasey, Anaya-McKivergan, Myers, and Huybrechts) and “Comparison of DSM-IV and DSM-5 Panel Members’ Financial Associations with Industry: A Pernicious Problem Persists” (with Sheldon Krimsky).


Following the presentation, American Medical Student Association, Education and Research Director, Jeffrey Koetje, MD will join us for a discussion designed to help to answer questions and connect participants with project resources and new tools available to help reduce conflicts of interest at academic medical centers and in the medical profession.


This event is offered as part of the Partnership to Advance Conflict-free Medical Education(PACME). This partnership and related materials were made possible by a grant from the state Attorney General Consumer and Prescriber Education Grant Program which is funded by the multi-state settlement of consumer fraud claims regarding the
marketing of the prescription drug Neurontin.

The Partnership to Advance Conflict‐free Medical Education (PACME) is a joint project of the National Physicians Alliance, the American Medical Student AssociationCommunity Catalyst, and the Pew Charitable Trusts designed to create both external and internal pressure for medical schools and academic medical centers to adopt strong new conflict-of-interest policies.

Learn more at NPAlliance.org/conflict-free